AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21465244
Drug: Control (CC)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (CC)
Trial: 15196153
Drug: RA/beta‐CD complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA/beta‐CD complex hydrogel formulation (0.025%)
Trial: 15196153
Drug: RA/beta‐CD complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA/beta‐CD complex hydrogel formulation
Trial: 15196153
Drug: RA/beta‐CD preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA/beta‐CD preparations
Trial: 11772826
Drug: Levobupivacaine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (12 mg)
Trial: 16430546
Drug: Bupivacaine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (12 mg)
Trial: 11772826
Drug: Levobupivacaine (4-12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (4-12 mg)
Trial: 11772826
Drug: Bupivacaine (4-12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (4-12 mg)
Trial: 10586386
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (2 mg) with ketoconazole (200 mg) given 2 hours prior to probes
Trial: 10586386
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (2 mg) with ketoconazole (200 mg) given simultaneously
Trial: 10586386
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (2 mg)
Trial: 8933995
Drug: Alniditan 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alniditan 1.2 mg
Trial: 11531899
Drug: Alniditan 1.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alniditan 1.4 mg
Trial: 10450538
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg mefloquine
Trial: 1860148
Drug: 1250 mg
RxNorm normalized name: bran 1250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1250 mg mefloquine
Trial: 6349649
Drug: Meclofenamate sodium
RxNorm normalized name: Meclofenamate Sodium
DrugBank: Meclofenamic acid (DB00939)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meclofenamate sodium (300 mg/day)
Trial: 27609756
Drug: Immediate combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate combination antiretroviral therapy (cART)
Trial: 24439714
Drug: FLUSH test
RxNorm normalized name: T8 Keto Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FLUSH test (agitated saline solution flush)
Trial: 23375921
Drug: Tooth-anchored treatment
RxNorm normalized name: Sus scrofa tooth preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tooth-anchored treatment group
Trial: 23375921
Drug: Bone-anchored treatment
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone-anchored treatment group
Trial: 20646352
Drug: Propolis and
RxNorm normalized name: propolis
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propolis and zinc suspension
Trial: 12954743
Drug: Buprenorphine (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (16 mg) and Naloxone (4 mg)
Trial: 12954743
Drug: Buprenorphine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine alone (16 mg)
Trial: 1577043
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release paracetamol 500 mg
Trial: 1577043
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release paracetamol 1000 mg
Trial: 1577043
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release paracetamol 2000 mg
Trial: 3001149
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 6 g/d for 6 d
Trial: 3001149
Drug: Docosahexaenoic acid
RxNorm normalized name: docosahexaenoic acid
DrugBank: Doconexent (DB03756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docosahexaenoic acid (DCHA) 6 g/d for 6 d
Trial: 25491243
Drug: Text or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text or animated conversational agent
Trial: 18672110
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (EE, IBU, PL)
Trial: 15962651
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg daily for 30 weeks
Trial: 8754377
Drug: Fraxiparin, antibiotic,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fraxiparin, antibiotic, Metronidazole, and prostaglandins
Trial: 2956865
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg enoximone
Trial: 2956865
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg enoximone
Trial: 7978427
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg enoximone
Trial: 2956865
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg enoximone
Trial: 2956865
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg enoximone
Trial: 29562983
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy (IPT) for at least 6 months
Trial: 21859733
Drug: Second-generation tyrosine
RxNorm normalized name: Tyrosine
DrugBank: Tyrosine (DB00135)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second-generation tyrosine kinase inhibitors (nilotinib or dasatinib)
Trial: 21859733
Drug: Interferon-α therapy
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-α therapy (control group)
Trial: 17074639
Drug: AZD7009 (3‐hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD7009 (3‐hour intravenous infusion)
Trial: 9950305
Drug: Isoprinosine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoprinosine (50 mg/kg per day for 6 weeks followed by 50 mg/kg per day twice weekly for 6 weeks)
Trial: 31719010
Drug: Conventional non-antibiotic
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional non-antibiotic suture
Trial: 25335249
Drug: Care group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Care group (psychological treatment)
Trial: 20855064
Drug: MMC (magnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMC (magnetic maneuverable capsule)
Trial: 20855064
Drug: ESO2 (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESO2 (conventional capsule)
Trial: 17221169
Drug: Low-dose doxycycline
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose doxycycline (20 mg) b.i.d for 3 months plus scaling and root planing (SRP)
Trial: 17221169
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules b.i.d for 3 months plus scaling and root planing (SRP)
Trial: 12926129
Drug: CT +
RxNorm normalized name: Aveeno Protect + Hydrate SPF70 Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT + RT (three courses of chemotherapy followed by radiotherapy)
Trial: 2349253
Drug: Cocaine-base 10
RxNorm normalized name: cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine-base 10 mg
Trial: 2349253
Drug: Cocaine-base 20
RxNorm normalized name: cocaine 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine-base 20 mg
Trial: 2349253
Drug: Cocaine-base 40
RxNorm normalized name: cocaine 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine-base 40 mg
Trial: 106428
Drug: Ciclazindol 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclazindol 50 mg orally
Trial: 25366969
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose budesonide/formoterol (HDBF) 640/18 μg
Trial: 25366969
Drug: Budesonide/formoterol maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol maintenance and reliever therapy (BFMRT)
Trial: 25366969
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (terbutaline 1 mg)
Trial: 25366969
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (lower dose budesonide/formoterol)
Trial: 24398815
Drug: Computerised treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerised treatment group
Trial: 18945254
Drug: ROSE-010 (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ROSE-010 (both doses)
Trial: 17763150
Drug: Aspirin treatment
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin treatment (81, 162 and 325 mg/day for 4 weeks each)
Trial: 16172177
Drug: Placebo-controlled intervention,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo-controlled intervention, average trial size of 32 subjects at 5 dose levels.
Trial: 16172177
Drug: Crossover designs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crossover designs (more frequent in early publications) and parallel single-dose designs.
Trial: 7383476
Drug: 1% econazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% econazole vaginal cream, used once daily at bedtime for 7 days
Trial: 7383476
Drug: 100‐mg clotrimazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100‐mg clotrimazole vaginal tablets, used once daily at bedtime for 7 days
Trial: 25085960
Drug: Percutaneous coronary
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous coronary revascularization with drug-eluting stents (DES-PCI)
Trial: 22520932
Drug: Valsartan/Hydrochlorothiazide (V/HCTZ)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan/Hydrochlorothiazide (V/HCTZ) 160/12.5 mg
Trial: 22520932
Drug: Valsartan (V)
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan (V) 160 mg
Trial: 10424505
Drug: HFA cromolyn
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFA cromolyn sodium (2 mg, two inhalations, qid for 12 weeks)
Trial: 10424505
Drug: CFC cromolyn
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CFC cromolyn sodium (2 mg, two inhalations, qid for 12 weeks)
Trial: 21478216
Drug: Mannitol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mannitol (400 mg b.i.d.)
Trial: 19583518
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment for ASB
Trial: 19583518
Drug: Treatment only
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment only for symptomatic infections
Trial: 17889086
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of iron daily in the second half of pregnancy
Trial: 15173273
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg zoledronic acid (via a 15-minute infusion every 3 weeks for 15 months)
Trial: 11346861
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg zoledronic acid
Trial: 11294919
Drug: Gabapentin 3,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 3,600 mg daily for 9 months
Trial: 3410944
Drug: Sterile skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile skin preparation technique
Trial: 29738561
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) amoxicillin/clavulanate 1750 mg IR twice a day (Period 2)
Trial: 29738561
Drug: Standard-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (SD) amoxicillin/clavulanate 875/125 mg IR
Trial: 29738561
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) amoxicillin/clavulanate 2000 mg ER (Period 1)
Trial: 29738561
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) amoxicillin/clavulanate
Trial: 29738561
Drug: Standard-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (SD) amoxicillin/clavulanate
Trial: 26251590
Drug: Endobronchial valve
RxNorm normalized name: VALVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endobronchial valve (EBV) therapy
Trial: 23979267
Drug: component therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: component therapy (COMP)
Trial: 21092076
Drug: docetaxel single-agent
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: docetaxel single-agent (D)
Trial: 19138237
Drug: Inhaled steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled steroid withdrawal for 12 weeks
Trial: 19138237
Drug: Inhaled steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled steroid treatment (before withdrawal)
Trial: 12113325
Drug: 1 mL
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mL 25% sucrose given orally 2 min before heel prick
Trial: 12113325
Drug: Milk intake
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk intake by nasogastric tube and 1 mL 25% sucrose given orally 2 min before heel prick
Trial: 15148453
Drug: Polymyxin B-immobilized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymyxin B-immobilized fiber (PMX-F) treatment
Trial: 1749827
Drug: Oral scopolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral scopolamine (1.2 mg)
Trial: 6762044
Drug: 3% acyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% acyclovir (ACV) eye ointment
Trial: 22383085
Drug: Esmolol (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (bolus of 0.5 mg·kg(‐1) iv at induction followed by infusion of 5‐15 μg·kg(‐1)·min(‐1))
Trial: 22383085
Drug: Remifentanil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil plus ketamine (bolus of ketamine 0.5 mg·kg(‐1) iv and remifentanil 0.5 μg·kg(‐1) iv at induction followed by a remifentanil infusion titrated over a range of 0.1‐0.5 μg·kg(‐1)·min(‐1))
Trial: 19403955
Drug: CCP (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCP (6 g/d CLA + 9 g/d C + 36 g/d P)
Trial: 16426124
Drug: Diclofenac (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (100 mg/daily) plus aescin (80 mg/daily)
Trial: 16426124
Drug: Diclofenac (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (100 mg/daily) plus aescin (80 mg/daily) plus tamsulosin (0.4 mg/daily)
Trial: 8787684
Drug: Oltipraz 500
RxNorm normalized name: Oltipraz
DrugBank: Oltipraz (DB12539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oltipraz 500 mg/m2
Trial: 8787684
Drug: Oltipraz 1000
RxNorm normalized name: Oltipraz
DrugBank: Oltipraz (DB12539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oltipraz 1000 mg/m2
Trial: 1485740
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy and pharmacologic therapy for 12 patients
Trial: 1485740
Drug: Pharmacologic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic therapy alone for 21 patients
Trial: 15144165
Drug: Evidence-based medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based medicine (EBM) principles and methods
Trial: 16195625
Drug: Valsartan added
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan added to conventional treatment (V group)
Trial: 16195625
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (C group)
Trial: 7556834
Drug: 0.3% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3% chlorhexidine gel
Trial: 7556834
Drug: Chlorhexidine gel
RxNorm normalized name: chlorhexidine Oral Gel
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine gel vs combined placebo plus control group
Trial: 2288318
Drug: Pitressin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitressin (6 or 10 units) administered by subcutaneous injection 30 minutes prior to contrast medium injection
Trial: 2288318
Drug: Routine procedure
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Routine procedure (laxatives the previous night and NPO the morning of the examination)
Trial: 31006142
Drug: Laser-assisted hair
RxNorm normalized name: cat hair extract
DrugBank: Felis catus hair (DB10499)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser-assisted hair removal treatment by trained nurses
Trial: 23371961
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment
Trial: 28279480
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with lower trust in treatment
Trial: 16248986
Drug: Aprepitant 80
RxNorm normalized name: aprepitant 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant 80 mg
Trial: 17525168
Drug: Aprepitant 125
RxNorm normalized name: aprepitant 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant 125 mg
Trial: 21866658
Drug: Danshen Chuanxiongqin
RxNorm normalized name: DANSHEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danshen Chuanxiongqin Injection (DCI) 10 mL intravenously dripped in 250 mL normal saline, once daily for 7 to 10 days before PCI
Trial: 21866658
Drug: Danshen Chuanxiongqin
RxNorm normalized name: DANSHEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danshen Chuanxiongqin Injection (DCI)
Trial: 21866658
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment of Western medicine and PCI (Control group)
Trial: 19512973
Drug: Acute ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute ketamine administration (low dose: 75 ng/mL; high dose: 150 ng/mL)
Trial: 20153142
Drug: Non-drug-using controls
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-drug-using controls
Trial: 16624928
Drug: Infliximab (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (a monoclonal antibody to TNF)
Trial: 16624928
Drug: Etanercept (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (a soluble TNF receptor fusion protein)
Trial: 8268901
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (antihypertensive treatment)
Trial: 4037442
Drug: Glucose +
RxNorm normalized name: Fora Test N'GO Advance Blood Glucose + B-Ketone Monitoring System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose + 100 mg X kg‐1 X d‐1 of ketoleucine (Group B)
Trial: 4037442
Drug: Glucose +
RxNorm normalized name: Fora Test N'GO Advance Blood Glucose + B-Ketone Monitoring System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose + 200 mg X kg‐1 X d‐1 of ketoleucine (Group C)
Trial: 28444716
Drug: Soft-chew formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft-chew formulation (100 mg ibuprofen)
Trial: 28444716
Drug: Hard tablet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hard tablet (reference, 100 mg ibuprofen)
Trial: 28444716
Drug: Soft-chew formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft-chew formulation (3 chews)
Trial: 28444716
Drug: Soft-chew formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft-chew formulation (8 chews)
Trial: 22802437
Drug: Hygiene promotion
RxNorm normalized name: PROMOTE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hygiene promotion and water treatment intervention
Trial: 16213034
Drug: Stimulant medication
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant medication in ADHD/C subjects
Trial: 12559061
Drug: 10 weekly
RxNorm normalized name: donepezil
DrugBank: Donepezil (DB00843)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10 weekly group sessions emphasizing food label information
Trial: 9581027
Drug: meso‐2,3‐dimercaptosuccinic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meso‐2,3‐dimercaptosuccinic acid (DMSA) at a dose of 30 mg kg‐1
Trial: 9581027
Drug: D,L‐2,3‐dimercaptopropane‐1‐sulfonic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D,L‐2,3‐dimercaptopropane‐1‐sulfonic acid (DMPS) at a dose of 30 mg kg‐1
Trial: 8068949
Drug: Chemotherapy arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy arm (T-ALL patients: 26, B-ALL patients: 57)
Trial: 28848332
Drug: CGA unit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGA unit treatment
Trial: 25168034
Drug: Lozenge +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lozenge + Coach Calls (n = 357)